Autologous dendritic cell vaccine (University of Barcelona)

自体树突状细胞疫苗 (巴塞罗那大学)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAutologous dendritic cell vaccine (University of Barcelona)

Drug Alias Nameautologous dendritic cell vaccine (HIV-1 infection)

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesUniversitat De Barcelona

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesUniversitat De Barcelona

Active IndicationsN/A

Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A